[The regulatory framework for complementary and alternative medicines in Europe]
- PMID: 18584103
- DOI: 10.1007/s00103-008-0584-8
[The regulatory framework for complementary and alternative medicines in Europe]
Abstract
Medicinal products from complementary and alternative medicine are in Germany a regular part of the health care system. Herbal, homeopathic, anthroposophic and traditional medicinal products are highly accepted by the population. The German Medicines Act obliged the competent authorities to consider the particular characteristics of complementary and alternative medicines. The European regulatory framework defined the status of herbal medicinal products, traditional herbal medicinal products and homeopathic medicinal products within the directive 2001/83/EC. The committee for herbal medicinal products (HMPC) was established at the European Medicines Agency in London (EMEA); for homeopathic medicinal products there is a specific working group established by the Heads of Medicines Agencies. Harmonisation of medicinal products from complementary and alternative and traditional medicine in Europe was enforced by implementation of directive 2001/83/EC in national legislations of member states. The provisions of this directive will substantially influence the development of the European market during the forthcoming years.
Similar articles
-
[Review of the development in European Legislation on the harmonisation of the laws for medicinal products].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jul;51(7):713-21. doi: 10.1007/s00103-008-0577-7. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008. PMID: 18584107 Review. German.
-
Granting marketing authorisation for medicines in South East European countries: the point of view of the authority.Regul Toxicol Pharmacol. 2010 Jul-Aug;57(2-3):325-32. doi: 10.1016/j.yrtph.2010.04.001. Epub 2010 Apr 10. Regul Toxicol Pharmacol. 2010. PMID: 20385190
-
[The role of the Committee for Medicinal Products for Human Use (CHMP) in the European centralised procedure].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008 Jul;51(7):731-9. doi: 10.1007/s00103-008-0579-5. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2008. PMID: 18584106 German.
-
The legal framework governing the quality of (traditional) herbal medicinal products in the European Union.J Ethnopharmacol. 2014 Dec 2;158 Pt B:449-53. doi: 10.1016/j.jep.2014.07.044. Epub 2014 Jul 31. J Ethnopharmacol. 2014. PMID: 25086408
-
European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.Phytomedicine. 2018 Mar 15;42:219-225. doi: 10.1016/j.phymed.2018.03.048. Epub 2018 Mar 19. Phytomedicine. 2018. PMID: 29655689 Review.
Cited by
-
Curcumin: A Contact Allergen.J Clin Aesthet Dermatol. 2015 Nov;8(11):43-8. J Clin Aesthet Dermatol. 2015. PMID: 26705440 Free PMC article.
-
Diagnoses and visit length in complementary and mainstream medicine.BMC Complement Altern Med. 2010 Jan 25;10:3. doi: 10.1186/1472-6882-10-3. BMC Complement Altern Med. 2010. PMID: 20100343 Free PMC article.
-
Usage of Natural Health Products (NHPs) for respiratory diseases: user characteristics and NHP-Consumption behavior during the Covid-19 pandemic in Germany.BMC Complement Med Ther. 2023 Oct 21;23(1):372. doi: 10.1186/s12906-023-04180-9. BMC Complement Med Ther. 2023. PMID: 37865731 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical